These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 15773401

  • 1. [Comparative analysis of the major protective antigens production in Vibrio cholerae recombinant and producer strains of the classical biovar].
    Toporkov AV, Zadnova SP, Smirnova NI.
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):53-7. PubMed ID: 15773401
    [Abstract] [Full Text] [Related]

  • 2. [Isolation and phenotyping of Vibrio cholerae strains with the enhanced production of main protective antigens].
    Zadnova SP, Toporkov AV, Smirnova NI.
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (2):3-6. PubMed ID: 11548254
    [Abstract] [Full Text] [Related]

  • 3. [Strains of Vibrio cholerae serogroups O1 and O139 that produce the basic protective antigens].
    Smirnova NI, Livanova LF, Chekhovskaia GV, Eroshenko GA, Lazovskiĭ IuV, Zakharova TL.
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):47-51. PubMed ID: 10925874
    [Abstract] [Full Text] [Related]

  • 4. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M, Karlsson SL, Källgård S, Blomquist M, Ekman A, Nygren E, Holmgren J.
    Vaccine; 2011 Oct 06; 29(43):7505-13. PubMed ID: 21807059
    [Abstract] [Full Text] [Related]

  • 5. Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.
    Häse CC, Thai LS, Boesman-Finkelstein M, Mar VL, Burnette WN, Kaslow HR, Stevens LA, Moss J, Finkelstein RA.
    Infect Immun; 1994 Aug 06; 62(8):3051-7. PubMed ID: 8039872
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of the recombinant plasmid carrying the genes of cholera prophages CTX and RS1 on the expression of virulence and immunogenicity genes in the cholera pathogen].
    Smirnov NI, Zadnova SP, Toporkov AV.
    Mol Gen Mikrobiol Virusol; 2005 Aug 06; (3):3-8. PubMed ID: 16173391
    [Abstract] [Full Text] [Related]

  • 8. [The characteristics of the reactogenicity and immunological activity of a new cholera bivalent chemical vaccine based on the results of controlled trials].
    Sumarokov AA, Ivanov NR, Dzhaparidze MN, Rystsova EA, Reznikov IuB, Matusevich LIa, Nikitina GP, Eliseev IuIu, Adamova GV, Plotnikova MN.
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul 06; (7):55-8. PubMed ID: 1719716
    [Abstract] [Full Text] [Related]

  • 9. Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.
    Manning PA, Heuzenroeder MW, Yeadon J, Leavesley DI, Reeves PR, Rowley D.
    Infect Immun; 1986 Aug 06; 53(2):272-7. PubMed ID: 2426198
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
    Smirnova NI, Krepostnova IM, Livanova LF, Zadnova SP, Eremin SA, Il'ina TS.
    Mol Gen Mikrobiol Virusol; 2007 Aug 06; (4):7-13. PubMed ID: 18154075
    [Abstract] [Full Text] [Related]

  • 12. [Choleragen-anatoxin chemical cholera vaccine enriched with Ogawa O-antigen].
    Dzhaparidze MN, Nikitina GP, Kulikova VL, Popov AA, Naumov AV.
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Apr 06; (4):70-4. PubMed ID: 6204471
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J, Gibson JA, Pickering BS, Watnick PI.
    mSphere; 2018 Jun 27; 3(3):. PubMed ID: 29875145
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
    Thungapathra M, Sharma C, Gupta N, Ghosh RK, Mukhopadhyay A, Koley H, Nair GB, Ghosh A.
    Immunol Lett; 1999 Jun 01; 68(2-3):219-27. PubMed ID: 10424424
    [Abstract] [Full Text] [Related]

  • 18. Identification of the Vibrio cholerae type 4 prepilin peptidase required for cholera toxin secretion and pilus formation.
    Marsh JW, Taylor RK.
    Mol Microbiol; 1998 Sep 01; 29(6):1481-92. PubMed ID: 9781884
    [Abstract] [Full Text] [Related]

  • 19. Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.
    Butterton JR, Boyko SA, Calderwood SB.
    Vaccine; 1993 Oct 01; 11(13):1327-35. PubMed ID: 8296486
    [Abstract] [Full Text] [Related]

  • 20. Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.
    Sanchez J, Holmgren J.
    Proc Natl Acad Sci U S A; 1989 Jan 01; 86(2):481-5. PubMed ID: 2492108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.